期刊文献+

冠状动脉植入支架术后发生支架内再狭窄的影响因素探究 被引量:7

The Influence Factors of Stent Restenosis Implanted in Coronary Artery
下载PDF
导出
摘要 冠状动脉粥样硬化性心脏病(冠心病)的发病率呈逐年上升的趋势,而其治疗方法已经不再局限于单纯的药物治疗。冠状动脉介入治疗已迅速发展起来,特别是冠状动脉支架植入术的广泛应用,为冠心病的治疗带来了新的希望。但术后支架内再狭窄的问题却逐步凸显出来,成为目前亟待解决的问题。导致冠状动脉支架内再狭窄的影响因素众多,引起学者们关注的因素主要有吸烟、高血压、糖尿病、血脂、支架、病变部位及类型等。因此,为了降低冠状动脉支架内再狭窄的发生率,需要通过众多因素的共同预防,才能使支架术后患者获得令人满意的远期疗效。 There is an upward trend in the incidence of coronary heart disease, and the treatment is no longer confined to simple drug treatment. Coronary artery interventional therapy has been developed rapidly, especially the wide application of coronary artery stent implantation, which has brought new hope for the treatment of coronary heart disease. However, the problem of stent restenosis after procedure is gradually highlighted and has become a problem to be solved at present. Among many affected factors leading to restenosis in stent, the major factors include smoking, high blood pressure, diabetes,lipid, stents, region and type of lesions and so on. Therefore,in order to reduce the incidence of coronary stent restenosis, many factors of prevention are necessary, which can make the patients get satisfactory long-term curative effect.
出处 《医学综述》 2014年第23期4297-4299,共3页 Medical Recapitulate
基金 中国医师协会阳光心血管研究基金(SCRFCMDA201214)
关键词 冠状动脉粥样硬化性心脏病 支架内再狭窄 影响因素 Coronary atherosclerotic heart disease In-stent restenosis Inluence factors
  • 相关文献

参考文献28

  • 1Scheen AJ,Warzée F,Legrand VM.Drug-eluting stents:meta-analysis in diabetic patients[J].Eur Heart J,2004,25(23):2167-2168.
  • 2苗军,崔连群.药物洗脱支架对糖尿病小血管再狭窄的影响[J].山东医药,2006,46(31):44-45. 被引量:2
  • 3魏广和,刘立新,王铁成,王建军,高荣华,张韶辉.吡格列酮降低非糖尿病患者冠状动脉药物洗脱支架再狭窄的研究[J].临床心血管病杂志,2012,28(6):445-448. 被引量:7
  • 4Nishio K,Sakurai M,Kusuyama T,et al.A randomized comparison of pioglitazone to inhibit restenosis after coronary stenting in patients with type 2 diabetes[J].Diabetes Care,2006,29(1):101-106.
  • 5Douglas JS Jr,Holmes DR Jr,Kereiakes DJ,et al.Coronary stent restenosis in patients treated with cilostazol[J].Circulation,2005,112(18):2826-2832.
  • 6Lee SW,Park SW,Kim YH,et al.Comparison of triple versus dual antiplatelet therapy after drug-eluting stent implantation(from the DECLARE-Long trial)[J].Am J Cardiol,2007,100(7):1103-1108.
  • 7马文学,江志羔,古玉燕,毕健成,徐志奇,曾建新.瑞舒伐他汀和阿伐他汀对急性冠状动脉综合征患者血脂、超敏C-反应蛋白和冠状动脉支架植入术后再狭窄的影响[J].中国当代医药,2012,19(19):30-31. 被引量:22
  • 8Mulder HJ,Bal ET,Jukema JW,et al.Pravastatin reduces restenosis two years after percutaneous transluminal coronary angioplasty(REGRESS trial)[J].Am J Cardiol,2000,86(7):742-746.
  • 9Sun ZS,Zhou SH,Guan X.Impact of blood circulation on reendothelialization,restenosis and atrovastatin's restenosis prevention effects[J].Int J Cardiol,2008,128(2):261-268.
  • 10Robinson JG.Models for describing relations among the various statin drugs,low-desity lipoprotein cholesterol lowering,pleiotropic effects,and cardiovascular risk[J].Am J Cardiol,2008,101(7):1009-1015.

二级参考文献108

共引文献124

同被引文献56

引证文献7

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部